Company Overview
BICARA THERAPEUTICS INC.
BCAXRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-138M
2025 FY
Shares Outstanding
54,677M
2025 FY
EPS
-2.52USD
2025 FY
Company Information
SIC Code
2834
CIK Code
2023658
Exchange
Nasdaq
Location
US